Charles Elliott Sigal - 01 Mar 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
01 Mar 2023
Transactions value $
$56,816
Form type
4
Filing time
02 Mar 2023, 15:27:44 UTC
Previous filing
09 Jan 2023
Next filing
19 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Purchase $56.8K +2.5K +33.33% $22.73 10K 01 Mar 2023 By Sigal Family Investments, LLC F1, F2, F3
holding VIR Common Stock 9.78K 01 Mar 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sigal Family Investments, LLC on October 21, 2022, of which the reporting person is the manager.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.595 to $22.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F3 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.